HR
Howe & Rusling Portfolio holdings
AUM
$1.35B
1-Year Return
20.22%
This Quarter Return
-10.75%
1 Year Return
+20.22%
3 Year Return
+65.82%
5 Year Return
+120.71%
10 Year Return
+233.38%
AUM
$789M
AUM Growth
-$76.5M
(-8.8%)
Cap. Flow
+$28.6M
Cap. Flow
% of AUM
3.63%
Top 10 Holdings %
Top 10 Hldgs %
27.06%
Holding
1,208
New
170
Increased
298
Reduced
313
Closed
90
Top Buys
| 1 |
Lowe's Companies
LOW
|
+$6.12M |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$4.9M |
| 3 |
AstraZeneca
AZN
|
+$4.65M |
| 4 |
Johnson & Johnson
JNJ
|
+$2.25M |
| 5 |
Medtronic
MDT
|
+$2.15M |
Top Sells
| 1 |
Berkshire Hathaway Class B
BRK.B
|
+$8.16M |
| 2 |
Tyson Foods
TSN
|
+$4.42M |
| 3 |
Bank of America
BAC
|
+$3.82M |
| 4 |
Hasbro
HAS
|
+$3.68M |
| 5 |
US Bancorp
USB
|
+$2.85M |
Sector Composition
| 1 | Technology | 13.04% |
| 2 | Healthcare | 12.98% |
| 3 | Financials | 11.5% |
| 4 | Consumer Staples | 8.7% |
| 5 | Industrials | 7.73% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
926
BioCryst Pharmaceuticals
BCRX
$1.7B
| $1K | ﹤0.01% |
+100
| New | +$1K |
|
927
Beam Therapeutics
BEAM
$2.06B
| $1K | ﹤0.01% |
+25
| New | +$1K |
|
928
Bausch Health
BHC
$2.67B
| $1K | ﹤0.01% |
100
| – | – |
|
929
Global X Blockchain ETF
BKCH
$254M
| $1K | ﹤0.01% |
50
+28
| +127% | +$560 |
|
930
AB InBev
BUD
$116B
| $1K | ﹤0.01% |
+19
| New | +$1K |
|
931
Beyond Meat
BYND
$198M
| $1K | ﹤0.01% |
+30
| New | +$1K |
|
932
Cognyte Software
CGNT
$617M
| $1K | ﹤0.01% |
311
-30
| -9% | -$96 |
|
933
Cleveland-Cliffs
CLF
$5.35B
| $1K | ﹤0.01% |
56
| – | – |
|
934
Cambium Networks
CMBM
$18.8M
| $1K | ﹤0.01% |
44
| – | – |
|
935
Coherent
COHR
$15.5B
| $1K | ﹤0.01% |
+25
| New | +$1K |
|
936
Copart
CPRT
$46.5B
| $1K | ﹤0.01% |
48
+4
| +9% | +$83 |
|
937
Carvana
CVNA
$51.8B
| $1K | ﹤0.01% |
52
+34
| +189% | +$654 |
|
938
Definitive Healthcare
DH
$431M
| $1K | ﹤0.01% |
55
-43
| -44% | -$782 |
|
939
Doximity
DOCS
$13B
| $1K | ﹤0.01% |
+38
| New | +$1K |
|
940
DocuSign
DOCU
$16B
| $1K | ﹤0.01% |
20
+15
| +300% | +$750 |
|
941
Darden Restaurants
DRI
$24.7B
| $1K | ﹤0.01% |
12
-3
| -20% | -$250 |
|
942
Design Therapeutics
DSGN
$378M
| $1K | ﹤0.01% |
+44
| New | +$1K |
|
943
DXC Technology
DXC
$2.58B
| $1K | ﹤0.01% |
19
| – | – |
|
944
Ericsson
ERIC
$26.7B
| $1K | ﹤0.01% |
100
+29
| +41% | +$290 |
|
945
Evertec
EVTC
$2.18B
| $1K | ﹤0.01% |
30
-7
| -19% | -$233 |
|
946
First Foundation Inc
FFWM
$487M
| $1K | ﹤0.01% |
47
| – | – |
|
947
GoodRx Holdings
GDRX
$1.43B
| $1K | ﹤0.01% |
+150
| New | +$1K |
|
948
Gentex
GNTX
$6.19B
| $1K | ﹤0.01% |
47
-12
| -20% | -$255 |
|
949
Gossamer Bio
GOSS
$630M
| $1K | ﹤0.01% |
+100
| New | +$1K |
|
950
Chart Industries
GTLS
$8.96B
| $1K | ﹤0.01% |
8
| – | – |
|